Paper39910018
The Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Insufficient Weight Loss or Regain After Metabolic/Bariatric Surgery: A Systematic Review and Meta-analysis.
Kellett J and 8 others. Obes Surg, 2025. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. The Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Insufficient Weight Loss or Regain After Metabolic/Bariatric Surgery: A Systematic Review and Meta-analysis. Papers, record 39910018. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39910018
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Efficacy of Glucagon-like Peptide-1 (GLP-1) Receptor Agonists for Insufficient Weight Loss or Regain After Metabolic/Bariatric Surgery: A Systematic Review and Meta-analysis.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Weight Loss | Major topic |
| Bariatric Surgery | Major topic |
| Glucagon-Like Peptide-1 Receptor Agonists | Major topic |
| Weight Gain | Major topic |
| Obesity, Morbid | Major topic |
| Humans | |
| Treatment Outcome |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36044100 | GLP-1 Agonist to Treat Obesity and Prevent Cardiovascular Disease: What Have We Achieved so Far? | Curr Atheroscler Rep | 2022 | https://conductscience.org/library/papers/36044100 | PubMed |
| 2 | 35879524 | The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery-a Retrospective Analysis. | Obes Surg | 2022 | https://conductscience.org/library/papers/35879524 | PubMed |
| 3 | 20890771 | Physical activity in gastric bypass patients: associations with weight loss and psychosocial functioning at 12-month follow-up. | Obes Surg | 2011 | https://conductscience.org/library/papers/20890771 | PubMed |
| 4 | 36926678 | Definition, Mechanisms and Predictors of Weight Loss Failure After Bariatric Surgery. | J Metab Bariatr Surg | 2022 | https://conductscience.org/library/papers/36926678 | PubMed |
| 5 | 27091444 | Longer-Term Physiological and Metabolic Effects of Gastric Bypass Surgery. | Curr Diab Rep | 2016 | https://conductscience.org/library/papers/27091444 | PubMed |
| 6 | 32656729 | Liraglutide Augments Weight Loss After Laparoscopic Sleeve Gastrectomy: a Randomised, Double-Blind, Placebo-Control Study. | Obes Surg | 2021 | https://conductscience.org/library/papers/32656729 | PubMed |
| 7 | 33555451 | Weight Regain and Insufficient Weight Loss After Bariatric Surgery: Definitions, Prevalence, Mechanisms, Predictors, Prevention and Management Strategies, and Knowledge Gaps-a Scoping Review. | Obes Surg | 2021 | https://conductscience.org/library/papers/33555451 | PubMed |
| 8 | 36765019 | Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study. | Obes Surg | 2023 | https://conductscience.org/library/papers/36765019 | PubMed |
| 9 | 38531038 | GLP-1 receptor agonists: A review of glycemic benefits and beyond. | JAAPA | 2024 | https://conductscience.org/library/papers/38531038 | PubMed |
| 10 | 23645885 | A critical analysis of the clinical use of incretin-based therapies: Are the GLP-1 therapies safe? | Diabetes Care | 2013 | https://conductscience.org/library/papers/23645885 | PubMed |
| 11 | 36752995 | Weight Regain After Bariatric Surgery: Scope of the Problem, Causes, Prevention, and Treatment. | Curr Diab Rep | 2023 | https://conductscience.org/library/papers/36752995 | PubMed |
| 12 | 30022424 | Efficacy of High-Dose Liraglutide as an Adjunct for Weight Loss in Patients with Prior Bariatric Surgery. | Obes Surg | 2018 | https://conductscience.org/library/papers/30022424 | PubMed |
| 13 | 29206132 | Effect of Grazing Behavior on Weight Regain Post-Bariatric Surgery: A Systematic Review. | Nutrients | 2017 | https://conductscience.org/library/papers/29206132 | PubMed |
| 14 | 30326125 | Comparison of the Performance of Common Measures of Weight Regain After Bariatric Surgery for Association With Clinical Outcomes. | JAMA | 2018 | https://conductscience.org/library/papers/30326125 | PubMed |
| 15 | 20152736 | Effect of gastric bypass surgery on the incretins. | Diabetes Metab | 2009 | https://conductscience.org/library/papers/20152736 | PubMed |
| 16 | 11108273 | Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. | Endocrinology | 2000 | https://conductscience.org/library/papers/11108273 | PubMed |
| 17 | 25312671 | What is "grazing"? Reviewing its definition, frequency, clinical characteristics, and impact on bariatric surgery outcomes, and proposing a standardized definition. | Surg Obes Relat Dis | 2014 | https://conductscience.org/library/papers/25312671 | PubMed |
| 18 | 21885246 | Food quality, physical activity, and nutritional follow-up as determinant of weight regain after Roux-en-Y gastric bypass. | Nutrition | 2012 | https://conductscience.org/library/papers/21885246 | PubMed |
| 19 | 38717042 | Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes. | J Manag Care Spec Pharm | 2024 | https://conductscience.org/library/papers/38717042 | PubMed |
| 20 | 37494014 | Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery: The BARI-OPTIMISE Randomized Clinical Trial. | JAMA Surg | 2023 | https://conductscience.org/library/papers/37494014 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42861025 | Neuroendocrine regulation of appetite and energy balance in metabolic disorders. | IBRO Neurosci Rep | 2026 | https://conductscience.org/library/papers/42861025 | PubMed |
| 42802300 | Treatment With a GLP-1 Receptor Agonist Versus Reduction of the Gastrojejunal Anastomosis Diameter Using Endoscopic Argon Plasma Coagulation for Recurrent Weight Gain After Roux-en-Y Gastric Bypass. | Obes Surg | 2026 | https://conductscience.org/library/papers/42802300 | PubMed |
| 42716982 | Anesthetic Safety and Perioperative Outcomes in GLP-1 Receptor Agonist-Treated Patients Undergoing Lipoabdominoplasty. | Aesthetic Plast Surg | 2026 | https://conductscience.org/library/papers/42716982 | PubMed |
| 42174244 | Early Adjuvant Treatment with Semaglutide After Sleeve Gastrectomy in Patients with Class II-III Obesity: A Prospective Non-Randomized Controlled Study. | Obes Surg | 2026 | https://conductscience.org/library/papers/42174244 | PubMed |
| 42124786 | Beyond the Procedure: Revisiting the Technical Determinants of Sleeve Gastrectomy and Roux-en-Y Gastric Bypass. | J Metab Bariatr Surg | 2026 | https://conductscience.org/library/papers/42124786 | PubMed |
| 41998485 | Metabolic Outcomes and Recurrent Weight Gain 10 Years After Roux-en-Y Gastric Bypass, a Longitudinal Cohort Study. | Obes Surg | 2026 | https://conductscience.org/library/papers/41998485 | PubMed |
| 41954719 | Glucagon-Like Peptide-1 Receptor Agonists vs. Bariatric Endoscopy: A Systematic Review and Meta Analysis of Efficacy, Safety, and Metabolic Outcomes. | Obes Surg | 2026 | https://conductscience.org/library/papers/41954719 | PubMed |
| 41870658 | The effect of endoscopic transoral outlet reduction (TORe) on weight recidivism and insufficient weight loss following one-anastomosis gastric bypass (OAGB). : Tore after OAGB for weight recidivism. | Langenbecks Arch Surg | 2026 | https://conductscience.org/library/papers/41870658 | PubMed |
| 41799164 | Analysis of factors influencing weight regain after bariatric-metabolic surgery in obesity hypoventilation syndrome patients based on gastrointestinal peptide hormones. | J Med Biochem | 2025 | https://conductscience.org/library/papers/41799164 | PubMed |
| 41774372 | Long-Term Outcomes of Pouch Resizing with Ring Augmentation for Dumping Syndrome and Weight Trajectory after Roux-en-Y Gastric Bypass: A Single-Center Experience. | Obes Surg | 2026 | https://conductscience.org/library/papers/41774372 | PubMed |
| 41767340 | Nutritional Vulnerability in RYGB Unmasked by GLP-1 Therapy. | ACG Case Rep J | 2026 | https://conductscience.org/library/papers/41767340 | PubMed |
| 41760866 | Long-term outcomes of metabolic and bariatric surgery: a 10-year study of effectiveness and predictors. | Int J Obes (Lond) | 2026 | https://conductscience.org/library/papers/41760866 | PubMed |
| 41701436 | Echocardiographic evaluation and clinical implications of cardiac remodeling in obesity. | J Echocardiogr | 2026 | https://conductscience.org/library/papers/41701436 | PubMed |
| 41644869 | Optimizing Safety and Outcomes in Metabolic/Bariatric Surgery: A Conceptual Framework for Staged Minimally Invasive Treatment. | Obes Surg | 2026 | https://conductscience.org/library/papers/41644869 | PubMed |
| 41299124 | Primary Care Providers Perspectives of GLP-1 Receptor Agonists to Manage Recurrent Weight Gain after Metabolic Bariatric Surgery - a Qualitative Study. | Obes Surg | 2026 | https://conductscience.org/library/papers/41299124 | PubMed |
| 40877612 | The role of glucagon-like peptide-1 receptor agonists in weight regain treatment or prevention after bariatric surgery: a systematic review and meta-analysis. | Eat Weight Disord | 2025 | https://conductscience.org/library/papers/40877612 | PubMed |
| 40836203 | The Role of Physical Activity in Minimizing Recurrence of Weight Gain Following Metabolic and Bariatric Surgery: Current Evidence and Suggestions for Advancing Future Research. | Curr Obes Rep | 2025 | https://conductscience.org/library/papers/40836203 | PubMed |
| 40603775 | GLP-1 Agonists in Aesthetic Surgery: Implications for Perioperative Outcomes and Body Contouring Procedures. | Aesthetic Plast Surg | 2025 | https://conductscience.org/library/papers/40603775 | PubMed |
| 40574486 | Weight Cycling Deregulates Eating Behavior in Mice via the Induction of Durable Gut Dysbiosis. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40574486 | PubMed |
| 40208455 | Eating Disorders in the Context of Metabolic and Bariatric Surgery: Current Status and Future Directions. | Curr Obes Rep | 2025 | https://conductscience.org/library/papers/40208455 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39910018
GET https://conductscience.org/api/papers/v1/39910018/references?page=2